Dr. Elke D. Aippersbach, MD, MS

Dr. Aippersbach practices at Affiliated Oncologists in Hazel Crest, Illinois.

Dr. Aippersbach's NPI, 1285754895, was assigned on March 29, 2007. Dr. Aippersbach graduated from University of Alberta in 2002. Dr. Aippersbach holds Illinois license 036117683.

Dr. Aippersbach's primary practice is Affiliated Oncologists, at 17750 Kedzie Ave, Hazel Crest, IL 60429 in Cook County. The practice phone is (310) 335-4000.

Dr. Aippersbach's primary practice is Affiliated Oncologists in Hazel Crest, Illinois. Dr. Aippersbach is also affiliated with Advocate Trinity Hospital. The medical group on file is Affiliated Oncologists. Dmand AI also links Dr. Aippersbach to 2 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aippersbach practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Aippersbach's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Aippersbach is board certified in radiation oncology by the American Board of Radiology. Dr. Aippersbach is licensed in Illinois.

Dmand AI lists bladder cancer radiation, bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, lung cancer radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Dr. Aippersbach treats.

CMS data shows 3,015 Medicare services from Dr. Aippersbach across 24 procedure codes in 2024, for 222 Medicare patients. Medicare paid $529,498 for them. Every service was in an office.

CMS counts 222 Medicare patients who saw Dr. Aippersbach in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have cancer, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aippersbach's median patient age at 72, with 67% women.

In 2024, Dr. Aippersbach wrote 66 Medicare Part D claims for 35 patients. 83% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $105 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

Dr. Aippersbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 223 general payments to Dr. Aippersbach from 59 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $438.

Dr. Aippersbach graduated from University of Alberta in 2002.

Dr. Aippersbach is in network with 19 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.